序号 |
标题 |
次数 |
作者 |
发布时间 |
71281 |
t-Boc-氨基氧基-四聚乙二醇-保护基团,t-Boc-Aminooxy-PEG4-CH2CO2-t-Bu |
98 |
wyh |
2024-12-24 |
71282 |
醛基-八聚乙二醇-叠氮,CHO-PEG8-azide |
135 |
wyh |
2024-12-24 |
71283 |
炔丙基-聚乙二醇4-琥珀酰亚胺碳酸酯,Propargyl-PEG4-CH2CO2-NHS |
142 |
wyh |
2024-12-24 |
71284 |
Val-Cit-PAB-OH,159857-79-1 ,ADC试剂 |
103 |
hyy |
2024-12-24 |
71285 |
Gastrodin Liposome,天麻素脂质体 |
149 |
axc |
2024-12-24 |
71286 |
Azido-PEG1-CH2CO2-NHS,CAS号:1480545-09-2 |
86 |
h |
2024-12-24 |
71287 |
Biotin-PEG3-(CH2)3-amine TFA salt ;生物素-PEG3-(CH2)3-氨基三氟乙酸盐 |
120 |
wyh |
2024-12-24 |
71288 |
PDP-Doxorubicin Liposome (PEGylated),PDP-阿霉素脂质体(聚乙二醇化) |
108 |
axc |
2024-12-24 |
71289 |
Azido-PEG5-CH2CO2-PFP,CAS号:2144777-92-2 |
131 |
h |
2024-12-24 |
71290 |
Boc-NHCH2CH2-PEG1-azide,CAS号:176220-30-7 |
78 |
h |
2024-12-24 |
71291 |
Boc-NH-PEG5-CH2COOH,叔丁氧羰基氨基-五聚乙二醇-乙酸 |
95 |
wyh |
2024-12-24 |
71292 |
Folate-Doxorubicin Liposome (PEGylated),叶酸-阿霉素脂质体(聚乙二醇化) |
110 |
axc |
2024-12-24 |
71293 |
Azido-PEG10-CH2CO2-NHS |
143 |
h |
2024-12-24 |
71294 |
Azide-Doxorubicin Liposome (PEGylated),叠氮阿霉素脂质体(聚乙二醇化) |
143 |
axc |
2024-12-24 |
71295 |
Azido-PEG3-CH2CO2Me,CAS号:1253389-31-9 |
109 |
h |
2024-12-24 |
71296 |
DBCO-Doxorubicin Liposome (PEGylated),DBCO-阿霉素脂质体(聚乙二醇化) |
102 |
axc |
2024-12-24 |
71297 |
Azido-PEG5-CH2CO2-NHS,CAS号:2144777-77-3 |
104 |
h |
2024-12-24 |
71298 |
DIBAC-GGFG-NH2CH2-Dxd,CAS号:2758875-01-1 |
80 |
h |
2024-12-24 |
71299 |
Amine-Doxorubicin Liposome (PEGylated),胺-阿霉素脂质体(聚乙二醇化) |
99 |
axc |
2024-12-24 |
71300 |
HO-PEG-CH2COOH (MW 35000) |
80 |
h |
2024-12-24 |
71301 |
Azido-PEG5-CH2CO2H,CAS号:217180-81-9 |
113 |
h |
2024-12-24 |
71302 |
Biotin-Doxorubicin Liposome (PEGylated),生物素-阿霉素脂质体(聚乙二醇化) |
84 |
axc |
2024-12-24 |
71303 |
H2N-PEG2-CH2COOtBu,CAS号:1122484-77-8 |
84 |
h |
2024-12-24 |
71304 |
H2N-PEG2-CH2COOH |
69 |
h |
2024-12-24 |
71305 |
Cyanur-Doxorubicin Liposome (PEGylated),氰尿多柔比星脂质体(聚乙二醇化) |
213 |
axc |
2024-12-24 |
71306 |
N3-PEG8-CH2COOH,CAS号:1343472-07-0 |
89 |
h |
2024-12-24 |
71307 |
PEG5-(CH2CO2t-Butyl)2的物理化学性质,211746-78-0 |
85 |
wyh |
2024-12-24 |
71308 |
Succinyl-Doxorubicin Liposome (PEGylated),琥珀酰阿霉素脂质体(聚乙二醇化) |
73 |
axc |
2024-12-24 |
71309 |
4-Ketobenztriazine-CH2COOH |
73 |
h |
2024-12-24 |
71310 |
MC-Val-Cit-PAB-PNP,159857-81-5 ,抗体- 药物偶联物 |
144 |
hyy |
2024-12-24 |
71311 |
Fmoc-Asp(OtBu)-CH2COOH,CAS号:1803002-89-2 |
91 |
h |
2024-12-24 |
71312 |
Fmoc-G-amino-CH2O acetyl-Exetecan的化学结构,1599440-09-1 |
131 |
wyh |
2024-12-24 |
71313 |
Carboxylic Acid-Doxorubicin Liposome (PEGylated),羧酸-阿霉素脂质体(聚乙二醇化) |
158 |
axc |
2024-12-24 |
71314 |
t-Butyl acetate-PEG2-CH2COOH,CAS号:883564-93-0 |
84 |
h |
2024-12-24 |
71315 |
Azido-PEG8-CH2COO-PFP,CAS号:2182601-80-3 |
67 |
h |
2024-12-24 |
71316 |
Control Doxorubicin Liposome (PEGylated),对照阿霉素脂质体(聚乙二醇化) |
97 |
axc |
2024-12-24 |
71317 |
Azido-PEG1-CH2CO2H,CAS号:79598-48-4 |
73 |
h |
2024-12-24 |
71318 |
Propargyl-PEG4-CH2CO2-NHS,CAS号:2144777-76-2 |
68 |
h |
2024-12-24 |
71319 |
Doxorubicin Liposome (PEGylated),阿霉素脂质体(聚乙二醇化) |
537 |
axc |
2024-12-24 |
71320 |
Cbz-NH-PEG3-CH2COOH,CAS号:462100-05-6 |
96 |
h |
2024-12-24 |
71321 |
Control High Potency Clodronate Liposome (Anionic),对照高效氯膦酸盐脂质体(阴离子) |
91 |
axc |
2024-12-24 |
71322 |
Cbz-NH-PEG2-CH2COOH,CAS号:165454-06-8,8-苄氧羰基氨基-3,6-二氧杂辛酸 |
88 |
h |
2024-12-24 |
71323 |
Cbz-NH-PEG5-CH2COOH,CAS号:1449390-66-2 |
89 |
h |
2024-12-24 |
71324 |
Cbz-NH-PEG1-CH2COOH,CAS号:1260092-43-0 |
126 |
h |
2024-12-24 |
71325 |
Fmoc-NH-PEG12-CH2COOH,CAS号:2291257-76-4 |
80 |
h |
2024-12-24 |